celastrol has been researched along with Cancer of the Retina in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, D; Feng, H; Guo, Z; Li, J; Li, Z; Zhang, J; Zhu, L | 1 |
| Chai, C; Guo, Z; Li, J; Li, Z; Shi, L; Yang, F; Zhang, J | 1 |
2 other study(ies) available for celastrol and Cancer of the Retina
| Article | Year |
|---|---|
Effectively suppressed angiogenesis-mediated retinoblastoma growth using celastrol nanomicelles.
Topics: Angiogenesis Inhibitors; Animals; Chick Embryo; Chorioallantoic Membrane; Dose-Response Relationship, Drug; Female; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Micelles; Nanoparticles; Neovascularization, Pathologic; Pentacyclic Triterpenes; Retinal Neoplasms; Retinoblastoma; Solubility; Triterpenes; Xenograft Model Antitumor Assays | 2020 |
Antiangiogenic and Antitumor Therapy for Retinoblastoma with Hypoxia-Inducible Factor-1α siRNA and Celastrol Co-Delivery Nanomicelles.
Topics: Angiogenesis Inhibitors; Cell Line, Tumor; Child; Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Pentacyclic Triterpenes; Retinal Neoplasms; Retinoblastoma; RNA, Small Interfering; Triterpenes; Tumor Microenvironment | 2020 |